In this episode - Issue #49: The Elephant of the GreensKeeper Value Fund's quarterly "Scorecard" for Q1 2025. Reporting a +3.0% net return for the fund despite challenging market conditions, including a significant selloff triggered by a President Trump tariff announcement. We cover the top-performing holdings—including Berkshire Hathaway, Vertex Pharmaceuticals, and Check Point Software Technologies—and the biggest laggards, notably Alphabet and American Express, emphasizing the fund's strategy of investing in well-capitalized, durable businesses. Also addressed are Canadian investors' concerns regarding the escalating US-Canada trade war and tariffs, advising against letting political views influence investment decisions and stressing the importance of rational, long-term value investing in global companies.